Culturally Tailored Educational Video to Promote Lung Cancer Screening in Vulnerable Communities

NCT06010355 | Terminated

• 2 other identifiers: iRISID-2022-1320JT 25584
• Study Type: interventional
• Target: 11
• Locations: 1 country
• Sites: 1

Brief Summary

This clinical trial evaluates the impact of a culturally tailored educational video on the perceptions of lung cancer and lung cancer screening in vulnerable communities. Lung cancer is the most common cancer type. African-American communities have a higher rate than any other racial or ethnic group in the United States and accounts for the highest number of deaths among African-Americans. Lung cancer is in the top three causes of cancer death among Asian men and women. Research has shown that low-income, minority and immigrant individuals may be under resourced to make decisions about prevention programs and early detection measures for lung cancer. A culturally tailored educational video may be an effective method to help people learn about lung cancer, susceptibility toward lung cancer and lung cancer screening. This may increase lung cancer screening in vulnerable communities.

Conditions

Cigarette Smoking-Related Carcinoma; Lung Carcinoma

Outcome Measures

Primary Outcomes (1)

• To understand barriers and opportunities for engaging three culturally distinct populations in lung cancer screening.

  Participants will be asked about their awareness of lung cancer screening, known or perceived barriers to screening, and potential opportunities or initiatives that could increase lung cancer screening rates in their community. Discussions will be audio recorded, transcribed by a professional transcription company, and analyzed by the study team using qualitative research methods.

  From baseline to endpoint, up to 1 year

Secondary Outcomes (2)

• To develop three culturally tailored educational videos about lung cancer and the benefits of lung cancer screening

  From baseline to endpoint, up to 1 year

• To test the impact of the videos on susceptibility to lung cancer, knowledge of lung cancer screening, and intentions to undergo lung cancer screening in a diverse sample of at-risk individuals.

  From baseline to endpoint, up to 1 year

Study Arms (3)

Arm I (Aim 1) (focus group)

EXPERIMENTAL

Participants participate in a focus group over 1 hour in support of the development of a culturally tailored educational video on study.

Procedure: Discussion

Arm II (Aim 2) (video, interview)

EXPERIMENTAL

Participants watch a culturally tailored educational video over 3-5 minutes and then immediately undergo an interview in support of the refinement of a culturally tailored educational video on study.

Other: Media Intervention; Other: Interview

Arm III (Aim 3) (video, test)

EXPERIMENTAL

Participants watch a culturally tailored educational video over 3-5 minutes and complete a brief test pre- and post-video over 30 minutes on study.

Other: Media Intervention; Other: Test

Interventions

Discussion PROCEDURE

Participate in focus groups

Also known as: Discuss

Arm I (Aim 1) (focus group)

Media Intervention OTHER

Watch culturally appropriate video

Arm II (Aim 2) (video, interview)

Interview OTHER

Undergo interview

Arm II (Aim 2) (video, interview)

Test OTHER

Complete test

Arm III (Aim 3) (video, test)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• AIM 1: Participants must be African American, Korean, or Chinese adults who have either: a history of smoking, a history of lung cancer, or who have undergone lung cancer screening
• AIM 2: Participants must be African American, Korean, or Chinese adults who have either: a history of smoking, a history of lung cancer, or who have undergone lung cancer screening
• AIM 3: Those who are African American, Korean or Chinese, and are eligible for lung cancer screening, based on current screening guidelines: Current or former smokers who are between 50 and 80 years of age and who have smoked at least one pack a day for 20 years or two packs a day for 10 years

You may not qualify if:

• AIM 1: Those excluded from participating include children; those who are not members of the African American, Chinese, or Korean community; those who do not have one of the following: a history of smoking, a history of lung cancer, or have undergone lung cancer screening
• AIM 2: Those excluded from participating include children; those who are not members of the African American, Chinese, or Korean community; those who do not have one of the following: a history of smoking, a history of lung cancer, or have undergone lung cancer screening
• AIM 3: Those excluded from participating include children; those who are not members of the African American, Chinese, or Korean community; those who do not have a history of smoking; those who have been diagnosed with lung cancer; those who have undergone lung cancer screening in the past

Sponsors & Collaborators

• Thomas Jefferson University: lead

Study Sites (1)

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, 19107, United States

Location

MeSH Terms

Conditions

Lung Neoplasms

Interventions

Interviews as Topic

Condition Hierarchy (Ancestors)

Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Amy R Leader, DrPH, MPH

  Thomas Jefferson University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: SCREENING
• Intervention Model: SEQUENTIAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 18, 2023
• First Posted: August 24, 2023
• Study Start: March 1, 2023
• Primary Completion: February 19, 2025
• Study Completion: February 19, 2025
• Last Updated: February 17, 2026

Record last verified: 2026-02

Locations

US (1)